Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).

Weinberg, BA; Gutierrez, M; Tesfaye, AA; Tan, MT; Noel, MS; He, AR; Mukherji, R; Marshall, J; Gleim, J; Bouker, K; Weiner, LM

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索